Logo Unibas Logo NNB
University of Basel
Neuroscience Network Basel
  • Neuroscience Network Basel

    A center of competence and excellence in neuroscience

  • Neuroscience Network Basel

    Explore function - Understand dysfunction - Improve diagnosis and treatment



Multiple sclerosis therapy improves gut flora
A medication used to treat MS also has a beneficial effect on the composition of the intestinal flora, according to researchers from the University of Basel and the University Hospital Basel. Conversely, the gut flora also plays a role in which side effects occur during treatment with the medication. More

Researchers discover a new function of the cerebellum
The cerebellum is known primarily for regulation of movement. Researchers at the University of Basel have now discovered that the cerebellum also plays an important role in remembering emotional experiences. More

Filippo Rijli elected to Accademia Nazionale dei Lincei
Filippo M. Rijli, group leader at the FMI and Professor in Neurobiology at the University of Basel, has been elected Member of the Italian Accademia Nazionale dei Lincei, one the world’s oldest and most prestigious scientific academies. More

SNSF Advanced Grant for Andreas Lüthi and Peter Scheiffele
The Swiss National Science Foundation has awarded Prof. Andreas Lüthi from the FMI and Prof. Peter Scheiffele from the Biozentrum, University of Basel, a highly endowed SNSF Advanced Grant. With the SNSF Advanced Grants, the SNSF supports leading scientists in Switzerland who take unconventional and often risky paths in their research to gain new insights. More

First ophthalmic gene therapy in Switzerland
We are proud to announce that the first ophthalmic gene therapy in Switzerland has been performed in the Eye Clinic of the University Hospital Basel. The gene therapy is available for patients with Leber congenital amaurosis and retinitis pigmentosa caused by mutations in the RPE65 gene – one out of 280 known disease genes that can cause retinal dystrophies. More

Multiple treatments to slow age-related muscle wasting
Everyone wants to stay fit and healthy as they grow old. But as we age, our body degrades, our muscles shrink and strength declines. Some older people suffer from excessive muscle loss, a condition known as sarcopenia. Researchers from the Biozentrum of the University of Basel show that a combination therapy could delay the onset of sarcopenia. This study has recently been published in “Nature Communications”. More

Brain Prize 2022 for Silvia Arber
Prof. Silvia Arber from the Biozentrum, University of Basel, and at the Friedrich Miescher Institute for Biomedical Research receives the renowned Brain Prize 2022. With this award, the Lundbeck Foundation recognizes this year's three prizewinners for their pioneering research into the neuronal circuits that control movement. More

“We generate tiny brains in the Petri dish"
Professor Verdon Taylor from the Department of Biomedicine at the University of Basel studies the development of the brain from stem cells, including using animal-free methods. Here, he explains which research questions can be answered using this approach – and why animal experiments are still needed. More

ERC Starting Grant for neurobiologist Anissa Kempf
How does our brain control sleep? A five-year European Research Council (ERC) Starting Grant is enabling Professor Anissa Kempf at the Biozentrum of the University of Basel to investigate the molecular basis of sleep. More


More news

Follow us on:

Upcoming NNB events

Neurosciences "from Bench-to-Bedside" Symposium on February 10th 2023
Woche des Gehirns vom 13. März bis 17. März 2023

Upcoming seminars

Seminar on Drug Sciences
Wednesday 23. November 2022 at 17:15 at Biozentrum U1.131
Speaker : Prof. Dr. Matthias Wymann (Cancer- and Immunobiology Group, Dept. of Biomedicine, University of Basel)
«Targeting the PI3K/mTOR pathway in cancer, immunity and neurodegenerative disease»
Host: Prof. D. Ricklin, Department of Pharmaceutical Sciences, University of Basel

Upcoming events

Monday 12th of December 2022 Neurex workshop
« HEARING LOSS: causes, consequences, therapies & IDORSIA PHARMACEUTICALS: Insight into CNS drug discovery »
Program and detailed information on: